Kenneth Weber, Ph.D., focuses his practice on patent prosecution, particularly in the
areas of molecular genetics, chemistry, pharmaceuticals, plant and agricultural
sciences, medical devices and microbial genetics. He regularly assists clients in patent
portfolio management, due diligence reviews, validity/infringement opinions and
Dr. Weber's clients include public and private corporations across the United States.
Representative corporate clients include Aqua Bounty Technologies; Avanir
Pharmaceuticals, Inc.; Merrimack Pharmaceuticals, Biosensors International Group;
and, Sun-Maid Growers. Representative clients in the bay area are Corcept
Therapeutics, Kalobios Pharmaceuticals; QuantumScape and Sutro Biopharma.
Dr. Weber provides a unique, collaborative approach to creating patent strategies for
companies with weak patent estates. Born out of years of evaluating startups for
investors and creating patent prosecution strategies for clients with repurposed drugs
or non-inventive medical devices, Dr. Weber’s proactive legal counsel maximizes the
opportunity to extract patentable inventions from routine experimentation and
Dr. Weber was recognized in 2016 and 2017 by The Best Lawyers in America® for